Asset Management One Co. Ltd. Acquires 3,592 Shares of Sabra Healthcare REIT, Inc. $SBRA

Asset Management One Co. Ltd. raised its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 0.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 469,510 shares of the real estate investment trust’s stock after buying an additional 3,592 shares during the quarter. Asset Management One Co. Ltd. owned 0.20% of Sabra Healthcare REIT worth $8,658,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in SBRA. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Sabra Healthcare REIT in the 1st quarter valued at $180,000. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Sabra Healthcare REIT by 4.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust’s stock valued at $331,000 after purchasing an additional 853 shares in the last quarter. Oppenheimer & Co. Inc. acquired a new stake in shares of Sabra Healthcare REIT in the 1st quarter valued at $578,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Sabra Healthcare REIT in the 1st quarter valued at $298,000. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Sabra Healthcare REIT by 1.1% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 257,900 shares of the real estate investment trust’s stock valued at $4,506,000 after purchasing an additional 2,790 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock opened at $18.34 on Tuesday. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03. The company has a market cap of $4.40 billion, a PE ratio of 24.13, a PEG ratio of 1.15 and a beta of 0.85. The company’s 50-day moving average is $18.64 and its two-hundred day moving average is $18.25.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same period in the prior year, the company posted $0.36 EPS. The company’s revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.5%. Sabra Healthcare REIT’s dividend payout ratio is 157.89%.

Analyst Upgrades and Downgrades

SBRA has been the topic of several recent analyst reports. BMO Capital Markets boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a research note on Monday, August 25th. National Bankshares set a $22.00 target price on shares of Sabra Healthcare REIT in a research note on Friday, October 17th. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price target on the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. Finally, JMP Securities upped their price target on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $20.75.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.